107 related articles for article (PubMed ID: 30346850)
1. RETRACTED ARTICLE: The Novel Effects of a Hydrolyzed Polysaccharide Dietary Supplement on Immune, Hepatic, and Renal Function in Adults with HIV in a Randomized, Double-Blind Placebo-Control Trial.
Lewis JE; Atlas SE; Abbas MH; Rasul A; Farooqi A; Lantigua LA; Michaud F; Goldberg S; Lages LC; Higuera OL; Fiallo A; Tiozzo E; Woolger JM; Ciraula S; Mendez A; Rodriguez A; Konefal J
J Diet Suppl; 2021; 18(2):I-XIII. PubMed ID: 30346850
[TBL] [Abstract][Full Text] [Related]
2. The Novel Effects of a Hydrolyzed Polysaccharide Dietary Supplement on Immune, Hepatic, and Renal Function in Adults with HIV in a Randomized, Double-Blind, Placebo-Control Trial.
Lewis JE; Atlas Bsn SE; Abbas MH; Rasul A; Farooqi A; Lantigua LA; Michaud F; Goldberg S; Lages LC; Higuera OL; Fiallo A; Tiozzo E; Woolger JM; Ciraula S; Mendez A; Rodriguez A; Konefal J
J Diet Suppl; 2020; 17(4):429-441. PubMed ID: 31146613
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular, endothelial function, and immune markers in response to treatment with a polysaccharide in HIV
Lewis JE; Atlas SE; Abbas MH; Rasul A; Farooqi A; Lantigua LA; Michaud F; Goldberg S; Lages LC; Gao J; Higuera OL; Fiallo A; Harvey PD; Tiozzo E; Woolger JM; Ciraula S; Mendez A; Rodriguez A; Konefal J
J Clin Transl Res; 2020 Apr; 5(3):140-147. PubMed ID: 32637718
[TBL] [Abstract][Full Text] [Related]
4. The Effect of a Hydrolyzed Polysaccharide Dietary Supplement on Biomarkers in Adults with Nonalcoholic Fatty Liver Disease.
Lewis JE; Atlas SE; Higuera OL; Fiallo A; Rasul A; Farooqi A; Kromo O; Lantigua LA; Tiozzo E; Woolger JM; Goldberg S; Mendez A; Rodriguez AE; Konefal J
Evid Based Complement Alternat Med; 2018; 2018():1751583. PubMed ID: 29853945
[TBL] [Abstract][Full Text] [Related]
5. Rice Bran Arabinoxylan Compound and Quality of Life (RBAC-QoL) of Cancer Patients: An Interim Analysis of the RBAC-QoL Study.
Ooi SL; Micalos PS; Zielinski R; Pak SC
Cureus; 2024 Jan; 16(1):e53188. PubMed ID: 38425632
[TBL] [Abstract][Full Text] [Related]
6. Effect of the serotonin receptor agonist, buspirone, on immune function in HIV-infected individuals: a six-month randomized, double-blind, placebo-controlled trial.
Eugen-Olsen J; Benfield T; Axen TE; Parner J; Iversen J; Pedersen C; Nielsen JO
HIV Clin Trials; 2000; 1(1):20-6. PubMed ID: 11590486
[TBL] [Abstract][Full Text] [Related]
7. The Health-Promoting Properties and Clinical Applications of Rice Bran Arabinoxylan Modified with Shiitake Mushroom Enzyme-A Narrative Review.
Ooi SL; Pak SC; Micalos PS; Schupfer E; Lockley C; Park MH; Hwang SJ
Molecules; 2021 Apr; 26(9):. PubMed ID: 33925340
[TBL] [Abstract][Full Text] [Related]
8. Rice bran arabinoxylan compound as a natural product for cancer treatment - an evidence-based assessment of the effects and mechanisms.
Ooi SL; Micalos PS; Kim J; Pak SC
Pharm Biol; 2024 Dec; 62(1):367-393. PubMed ID: 38745507
[TBL] [Abstract][Full Text] [Related]
9. Rice bran arabinoxylan compound and quality of life of cancer patients (RBAC-QoL): Study protocol for a randomized pilot feasibility trial.
Ooi SL; Pak SC; Micalos PS; Schupfer E; Zielinski R; Jeffries T; Harris G; Golombick T; McKinnon D
Contemp Clin Trials Commun; 2020 Sep; 19():100580. PubMed ID: 32548333
[TBL] [Abstract][Full Text] [Related]
10. Modified Rice Bran Arabinoxylan by
Ooi SL; Micalos PS; Pak SC
Molecules; 2023 Aug; 28(17):. PubMed ID: 37687141
[TBL] [Abstract][Full Text] [Related]
11. The immunomodulatory nutritional intervention NR100157 reduced CD4+ T-cell decline and immune activation: a 1-year multicenter randomized controlled double-blind trial in HIV-infected persons not receiving antiretroviral therapy (The BITE Study).
Cahn P; Ruxrungtham K; Gazzard B; Diaz RS; Gori A; Kotler DP; Vriesema A; Georgiou NA; Garssen J; Clerici M; Lange JM;
Clin Infect Dis; 2013 Jul; 57(1):139-46. PubMed ID: 23511299
[TBL] [Abstract][Full Text] [Related]
12. Modified rice bran arabinoxylan as a nutraceutical in health and disease-A scoping review with bibliometric analysis.
Ooi SL; Micalos PS; Pak SC
PLoS One; 2023; 18(8):e0290314. PubMed ID: 37651416
[TBL] [Abstract][Full Text] [Related]
13. Randomized, placebo-controlled trial of Chinese herb therapy for HIV-1-infected individuals.
Weber R; Christen L; Loy M; Schaller S; Christen S; Joyce CR; Ledermann U; Ledergerber B; Cone R; Lüthy R; Cohen MR
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):56-64. PubMed ID: 10534147
[TBL] [Abstract][Full Text] [Related]
14. Effects of Prednisolone on Disease Progression in Antiretroviral-Untreated HIV Infection: A 2-Year Randomized, Double-Blind Placebo-Controlled Clinical Trial.
Kasang C; Kalluvya S; Majinge C; Kongola G; Mlewa M; Massawe I; Kabyemera R; Magambo K; Ulmer A; Klinker H; Gschmack E; Horn A; Koutsilieri E; Preiser W; Hofmann D; Hain J; Müller A; Dölken L; Weissbrich B; Rethwilm A; Stich A; Scheller C
PLoS One; 2016; 11(1):e0146678. PubMed ID: 26812052
[TBL] [Abstract][Full Text] [Related]
15. Micronutrient supplementation in adults with HIV infection.
Visser ME; Durao S; Sinclair D; Irlam JH; Siegfried N
Cochrane Database Syst Rev; 2017 May; 5(5):CD003650. PubMed ID: 28518221
[TBL] [Abstract][Full Text] [Related]
16. Effects of Immunonutrition in Advanced Human Immunodeficiency Virus Disease: A Randomized Placebo-controlled Clinical Trial (Promaltia Study).
Serrano-Villar S; de Lagarde M; Vázquez-Castellanos J; Vallejo A; Bernadino JI; Madrid N; Matarranz M; Díaz-Santiago A; Gutiérrez C; Cabello A; Villar-García J; Blanco JR; Bisbal O; Sainz T; Moya A; Moreno S; Gosalbes MJ; Estrada V
Clin Infect Dis; 2019 Jan; 68(1):120-130. PubMed ID: 29788075
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.
Currier JS; Williams PL; Koletar SL; Cohn SE; Murphy RL; Heald AE; Hafner R; Bassily EL; Lederman HM; Knirsch C; Benson CA; Valdez H; Aberg JA; McCutchan JA
Ann Intern Med; 2000 Oct; 133(7):493-503. PubMed ID: 11015162
[TBL] [Abstract][Full Text] [Related]
18. Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection.
Eron JJ; Ashby MA; Giordano MF; Chernow M; Reiter WM; Deeks SG; Lavelle JP; Conant MA; Yangco BG; Pate PG; Torres RA; Mitsuyasu RT; Twaddell T
Lancet; 1996 Dec; 348(9041):1547-51. PubMed ID: 8950881
[TBL] [Abstract][Full Text] [Related]
19. A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
García F; Romeu J; Grau I; Sambeat MA; Dalmau D; Knobel H; Gomez-Sirvent JL; Arrizabalaga J; Cruceta A; Clotet BG; Podzamczer D; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM
AIDS; 1999 Dec; 13(17):2377-88. PubMed ID: 10597779
[TBL] [Abstract][Full Text] [Related]
20. Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment.
Heseltine PN; Goodkin K; Atkinson JH; Vitiello B; Rochon J; Heaton RK; Eaton EM; Wilkie FL; Sobel E; Brown SJ; Feaster D; Schneider L; Goldschmidts WL; Stover ES
Arch Neurol; 1998 Jan; 55(1):41-51. PubMed ID: 9443710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
